Posts Tagged ‘ASCO’

New data at ASCO Show Gleevec ® Novartis drug Tasigna ® than for patients with newly diagnosed CML

New Data at ASCO Show Novartis Drug Tasigna® Surpasses Gleevec® for Newly Diagnosed CML Patients
Novartis announced today 18-month results showing that Tasigna® capsules significantly surpass the efficacy of Gleevec® tablets* in adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.

Read more on PR Newswire via Yahoo! Finance



Related Blogs

New data at ASCO Show Novartis drug Gleevec ® Tasigna ® than for patients with newly diagnosed CML

New Data at ASCO Show Novartis Drug Tasigna® Surpasses Gleevec® for Newly Diagnosed CML Patients
Novartis announced today 18-month results showing that Tasigna® capsules significantly surpass the efficacy of Gleevec® tablets* in adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.

Read more on PR Newswire via Yahoo! Finance



Related Blogs

In a promising drug for patients with Novartis ASCO deadly diseases such as CML, multiple myeloma. . .

Data At ASCO Show Promise Of Novartis Drugs For Patients With Life-Threatening Diseases Like CML, Multiple Myeloma And …
Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG, announced that nearly 170 abstracts highlighting investigational uses of current therapies and investigational agents in the Novartis Oncology portfolio will be presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) from June 4 through June 8 in Chicago, IL (1)…

Read more on Medical News Today



Related Blogs

Contact Us | Terms of Use | Privacy Statement